Global Fibrinolytic Capacity in Pediatric Patients With Sepsis and Disseminated Intravascular Coagulation
dc.authorscopusid | 8930720100 | |
dc.authorscopusid | 7005791514 | |
dc.authorscopusid | 6507549428 | |
dc.authorscopusid | 14526773500 | |
dc.contributor.author | Bay, Ali | |
dc.contributor.author | Oner, Ahmet Faik | |
dc.contributor.author | Kose, Dogan | |
dc.contributor.author | Dogan, Murat | |
dc.date.accessioned | 2025-05-10T17:07:24Z | |
dc.date.available | 2025-05-10T17:07:24Z | |
dc.date.issued | 2006 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | Yuzuncu Yil Univ, Tip Fak, Arastirma Hastanesi Cocuk Serv, TR-65200 Van, Turkey | en_US |
dc.description.abstract | There are many complex pathophysiologic changes of the coagulation system in sepsis. The fibrinolytic system was evaluated in septic children using the global fibrinolytic capacity (GFC), a new technique reflecting the overall fibrinolytic activity. The study consisted of 24 children with sepsis, 36 children with sepsis plus disseminated intravascular coagulation (DIC), and 20 healthy age-matched control individuals. Compared with controls, 86% of sepsis patients and 87% of sepsis plus DIC patients had decreased GFC levels. Between the sepsis plus DIC and sepsis groups there was no significant difference in terms of GFC levels. While 19 patients (52.7%) died in the sepsis plus DIC group, only three patients (112.5%) died in the sepsis group. When survivors and nonsurvivors were compared in terms of coagulation tests, there were significant differences for protein C, antithrombin, platelet, fibrinogen, aspartate aminotransferase, alanine aminotransferase, prothrombin time, and white blood cell values. In conclusion, the level of GFC reduced in most of the pediatric sepsis patients but no difference was observed between patients with sepsis and patients with sepsis plus DIC. While inhibition of fibrinolysis is an important finding in sepsis, the mortality is mainly associated with the presence of end-organ damage and the status of coagulation parameters. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1097/01.mbc.0000245304.95138.cf | |
dc.identifier.endpage | 573 | en_US |
dc.identifier.issn | 0957-5235 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 16988553 | |
dc.identifier.scopus | 2-s2.0-33748929320 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 569 | en_US |
dc.identifier.uri | https://doi.org/10.1097/01.mbc.0000245304.95138.cf | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/6759 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000245418600010 | |
dc.identifier.wosquality | Q4 | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Coagulation | en_US |
dc.subject | Global Fibrinolytic Capacity | en_US |
dc.subject | Sepsis | en_US |
dc.title | Global Fibrinolytic Capacity in Pediatric Patients With Sepsis and Disseminated Intravascular Coagulation | en_US |
dc.type | Article | en_US |